Embecta News

Embecta (EMBC.US): The 2024 Q2 financial report achieved revenue of US$287.2 million, prior value of US$277.1 million, expected value of US$264.7 million; earnings per share were US$0.67, previous value of $0.75, and expected value of US$0.40.

Embecta (EMBC.US): The 2024 Q2 financial report achieved revenue of US$287.2 million, prior value of US$277.1 million, expected value of US$264.7 million; earnings per share were US$0.67, previous value of $0.75, and expected value of US$0.40.

Zhitong Finance18:41

Embecta Declared Quarterly Cash Dividend Of $0.15 Per Share, Payable On June 14 To Stockholders Of Record At The Close Of Business On May 28

Embecta Declared Quarterly Cash Dividend Of $0.15 Per Share, Payable On June 14 To Stockholders Of Record At The Close Of Business On May 28

Benzinga18:38

Embecta Raises FY24 Revenue Outlook To $1.111B-$1.116B Vs. $1.11B Estimate (Prior View: $1.094B-$1.116B) ; Increases Adjusted Earnings Per Diluted Share Outlook To $2.20-$2.30 Vs. $2.10 Estimate (Prior View: $1.95 - $2.15)

Embecta Raises FY24 Revenue Outlook To $1.111B-$1.116B Vs. $1.11B Estimate (Prior View: $1.094B-$1.116B) ; Increases Adjusted Earnings Per Diluted Share Outlook To $2.20-$2.30 Vs. $2.10 Estimate (Prio

Benzinga18:37

GUIDANCE: (EMBC) EMBECTA Expects Fiscal Year 2024 EPS Range $2.20 - $2.30

06:34 AM EDT, 05/09/2024 (MT Newswires) -- GUIDANCE: (EMBC) EMBECTA Expects Fiscal Year 2024 EPS Range $2.20 - $2.30

MT Newswires18:34

Earnings Flash (EMBC) EMBECTA Reports Q2 EPS $0.67

06:34 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (EMBC) EMBECTA Reports Q2 EPS $0.67

MT Newswires18:34

Embecta Q2 Adj $0.67 Beats $0.40 Estimate, Sales $287.20M Beat $264.70M Estimate

Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.40 by 67.5 percent. This is a 10.67 percent decrease over earnings of $0.75 per sha

Benzinga18:33

Embecta Raises 2024 Guidance >EMBC

Embecta Raises 2024 Guidance >EMBC

Dow Jones18:32

Embecta 2Q Rev $287.2M >EMBC

Embecta 2Q Rev $287.2M >EMBC

Dow Jones18:30

Press Release: Embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. ("embecta") (Nasdaq: EMBC) has declared a quarterly cash dividend

Dow Jones18:00

Pleasing Signs As A Number Of Insiders Buy Embecta Stock

Yahoo FinanceMay 4 20:56

Embecta to Participate in Investor Events

PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in

GlobeNewswireMay 2 05:00

Embecta to Report Fiscal Second Quarter 2024 Financial Results

PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal

GlobeNewswireApr 24 05:00

Revelyst Announces Chief Supply Chain Officer

Business WireApr 23 19:00

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)

TipRanksApr 1 19:30

Embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at

GlobeNewswireMar 6 19:00

Embecta(EMBC.US) Director Buys US$32,500 in Common Stocks

$Embecta(EMBC.US)$ Director Melcher David F purchased 2,000 shares of Common Stocks on Feb 12, 2024 at an average price of $16.25 for a total value of $32,500.Source: Announcement What is statement of

Futu NewsFeb 13 08:49

Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)

TipRanksFeb 12 18:50

Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)

TipRanksFeb 12 01:01

Embecta Shareholders Approve Directors and Compensation Plans

TipRanksFeb 10 17:41

Embecta To Go Ex-Dividend On February 27th, 2024 With 0.15 USD Dividend Per Share

February 10th - $Embecta(EMBC.US)$ is trading ex-dividend on February 27th, 2024. Shareholders of record on February 28th, 2024 will receive 0.15 USD dividend per share on March 15th, 2024. The ex

Futu NewsFeb 10 08:40